Vascular anticoagulant β: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity

Authors:

Abstract
A cDNA was cloned coding for a new member of the human Ca2+‐modulated phospholipid‐binding protein family termed annexins. Due to its 56% identity to the human vascular anticoagulant (VAC) the new protein is named VAC‐β, renaming the previous VAC as VAC‐α. Northern analysis detects one hybridizing mRNA species of 2.2 kb in human placenta. Genomic Southern blot analysis shows a VAC‐β gene of comparable complexity to the VAC‐α gene. The cDNA was expressed in Escherichia coli and the recombinant protein purified to homogeneity. Antiserum raised against VAC‐β weakly cross‐reacts with VAC‐α. The properties of VAC‐β as an anticoagulant and as an inhibitor of phospholipase A2 activity were analyzed and compared to those of VAC‐α.